Lista de obras - Quentin M Anstee - Dominio Público Uruguay

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe

artículo científico publicado en 2019

A fatty liver leads to a broken heart?

artículo científico publicado en 2016

A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'?

scientific article published on 18 October 2011

A missense mutation in the non-neural G-protein alpha-subunit isoforms modulates susceptibility to obesity.

artículo científico publicado en 2009

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis ⬇️

artículo científico publicado en 2017

A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial

artículo científico publicado en 2019

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

scientific article published on 25 January 2019

Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis

scientific article published on 11 September 2020

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

artículo científico publicado en 2016

An overview of the genetics, mechanisms and management of NAFLD and ALD.

artículo científico publicado en 2015

Animal models in nonalcoholic steatohepatitis research: utility and clinical translation ⬇️

artículo científico publicado el 6 de febrero de 2011

Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants.

artículo científico publicado en 2018

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

scientific article published on 01 June 2013

Author Correction: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

scientific article published in Nature

Barriers and Facilitators to Mediterranean Diet Adoption by Patients with Non-alcoholic Fatty Liver Disease in Northern Europe

artículo científico publicado en 2018

Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis

artículo científico publicado en 2020

Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease

artículo científico publicado en 2012

Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey

artículo científico publicado en 2017

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

artículo científico publicado en 2014

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science.

artículo científico publicado en 2017

Cellular senescence drives age-dependent hepatic steatosis.

artículo científico publicado en 2017

Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?

scientific article published on 30 August 2018

Changing epidemiology of chronic liver disease among ethnic groups in the United States.

artículo científico publicado en 2016

Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).

artículo científico publicado en 2017

Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis.

artículo científico publicado en 2017

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

artículo científico publicado en 2016

Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease.

artículo científico publicado en 2015

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping

artículo científico publicado en 2020

Editorial: collagen proportionate area as a prognostic indicator in NAFLD

scientific article published on 01 June 2019

Editorial: hepatocellular carcinoma in non-cirrhotic NASH-a troubling reality

scientific article published on 01 November 2018

Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis

artículo científico publicado en 2007

Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers.

artículo científico publicado en 2017

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

artículo científico publicado en 2016

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

scientific article published on 07 April 2020

Erratum: Corrigendum: Multigenerational epigenetic adaptation of the hepatic wound-healing response

artículo científico publicado en 2012

Erratum: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

artículo científico publicado en 2017

European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale

artículo científico publicado en 2018

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

artículo científico publicado en 2014

Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.

scientific article published on 10 August 2016

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes

artículo científico publicado en 2020

Foreword. Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2015

From NASH to HCC: current concepts and future challenges

scientific article published on 01 July 2019

Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease

artículo científico publicado en 2014

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2016

Genetic modifiers of non-alcoholic fatty liver disease progression

artículo científico publicado en 2011

Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

artículo científico publicado en 2013

Genetic variation in GABRβ1 and the risk for developing alcohol dependence

artículo científico publicado en 2017

Genetics of Alcoholic Liver Disease

artículo científico publicado en 2015

Genetics of alcoholic liver disease and non-alcoholic steatohepatitis

artículo científico publicado en 2018

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation

artículo científico publicado en 2018

How big a problem is non-alcoholic fatty liver disease?

artículo científico publicado en 2011

How to Diagnose Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2016

Hypercoagulability in cirrhosis: causes and consequences.

artículo científico publicado en 2011

Impact of non-invasive biomarkers on hepatology practice: Past, present and future

scientific article published in 2022

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.

artículo científico publicado en 2010

Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD.

artículo científico publicado en 2017

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

artículo científico publicado en 2021

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

artículo científico publicado en 2017

Investigating mildly abnormal serum aminotransferase values

artículo científico publicado en 2010

Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice.

artículo científico publicado en 2017

Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma

artículo científico publicado en 2020

Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients

artículo científico publicado en 2014

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.

artículo científico publicado en 2017

Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

article

Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial

artículo científico publicado en 2015

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

artículo científico publicado en 2006

Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease.

artículo científico publicado en 2011

Multigenerational epigenetic adaptation of the hepatic wound-healing response

artículo científico publicado en 2012

Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice

artículo científico publicado en 2013

Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition

artículo científico publicado en 2013

NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD

artículo científico publicado en 2017

NAFLD: The evolving landscape

artículo científico publicado en 2017

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

artículo científico publicado en 2021

Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosis

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

artículo científico publicado en 2017

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls

artículo científico publicado en 2014

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

artículo científico publicado en 2014

Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis

artículo científico publicado en 2018

Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum.

artículo científico publicado en 2016

Nonalcoholic fatty liver disease: new treatments

artículo científico publicado en 2015

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

artículo científico publicado en 2019

Parenchymal extinction: coagulation and hepatic fibrogenesis.

artículo científico publicado en 2009

Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue

artículo científico publicado en 2009

Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience.

artículo científico

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease

artículo científico publicado en 2016

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany

article

Prophylaxis of bacterial infections in cirrhosis: is an optimal 25-OH vitamin D level required?

artículo científico publicado en 2014

Quantifying hepatic steatosis - more than meets the eye.

artículo científico publicado en 2012

REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis

artículo científico publicado en 2019

Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis

scientific article published on 16 February 2019

Reply

scientific article published on 11 February 2020

Reply to "Hepatocellular carcinoma and the Newcastle-upon-Tyne area"

artículo científico publicado en 2014

Reply to: "Caveats for the implementation of global strategies against non-alcoholic fatty liver disease"

artículo científico publicado en 2020

Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance

artículo científico publicado en 2015

Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD

artículo científico publicado en 2019

Republished: Non-alcoholic fatty liver disease: a practical approach to treatment.

artículo científico publicado en 2015

Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.

artículo científico

Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.

artículo científico publicado en 2016

Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study.

artículo científico publicado en 2017

Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease

scientific article published on 01 July 2018

Role of monocytes and macrophages in experimental and human acute liver failure

artículo científico publicado en 2010

S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility

artículo científico publicado en 2012

Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2014

TM6SF2 as a genetic risk factor for fibrosis

scientific article published on 19 June 2015

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2014

TM6SF2: Catch-22 in the Fight Against Nonalcoholic Fatty Liver Disease and Cardiovascular Disease?

artículo científico publicado en 2015

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2017

The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2.

artículo científico

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma

artículo científico publicado en 2017

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies

scientific article published on 12 July 2011

The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease

artículo científico publicado en 2017

The degree of hepatic steatosis associates with impaired cardiac and autonomic function

scientific article published on 13 February 2019

The genetics of NAFLD.

artículo científico publicado en 2013

The role of intestinal microbiota in murine models of acetaminophen-induced hepatotoxicity

artículo científico publicado en 2014

Therapeutic Inhibition of Inflammatory Monocyte Recruitment Reduces Steatohepatitis and Liver Fibrosis

artículo científico publicado en 2017

Thrombin and factor Xa link the coagulation system with liver fibrosis.

artículo científico publicado en 2018

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans

scientific article published on 13 October 2016

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

scientific article published on 01 December 2020

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis

artículo científico publicado en 2014

qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis

artículo científico publicado en 2019

Lista de obras de Quentin M Anstee

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe

A fatty liver leads to a broken heart?

A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'?

A missense mutation in the non-neural G-protein alpha-subunit isoforms modulates susceptibility to obesity.

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis ⬇️

A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

An overview of the genetics, mechanisms and management of NAFLD and ALD.

Animal models in nonalcoholic steatohepatitis research: utility and clinical translation ⬇️

Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants.

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

Author Correction: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Barriers and Facilitators to Mediterranean Diet Adoption by Patients with Non-alcoholic Fatty Liver Disease in Northern Europe

Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis

Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease

Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science.

Cellular senescence drives age-dependent hepatic steatosis.

Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?

Changing epidemiology of chronic liver disease among ethnic groups in the United States.

Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).

Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis.

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease.

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping

Editorial: collagen proportionate area as a prognostic indicator in NAFLD

Editorial: hepatocellular carcinoma in non-cirrhotic NASH-a troubling reality

Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis

Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers.

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

Erratum: Corrigendum: Multigenerational epigenetic adaptation of the hepatic wound-healing response

Erratum: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes

Foreword. Nonalcoholic Fatty Liver Disease

From NASH to HCC: current concepts and future challenges

Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease

Genetic modifiers of non-alcoholic fatty liver disease progression

Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

Genetic variation in GABRβ1 and the risk for developing alcohol dependence

Genetics of Alcoholic Liver Disease

Genetics of alcoholic liver disease and non-alcoholic steatohepatitis

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation

How big a problem is non-alcoholic fatty liver disease?

How to Diagnose Nonalcoholic Fatty Liver Disease

Hypercoagulability in cirrhosis: causes and consequences.

Impact of non-invasive biomarkers on hepatology practice: Past, present and future

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.

Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD.

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Investigating mildly abnormal serum aminotransferase values

Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice.

Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma

Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.

Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease.

Multigenerational epigenetic adaptation of the hepatic wound-healing response

Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice

Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition

NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD

NAFLD: The evolving landscape

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosis

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis